Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
about
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseA double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancersTriplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment.Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.Refining the treatment of advanced nonsmall cell lung cancer.Targeted therapy for non-small-cell lung cancer: past, present and future.Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trials.A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
P2860
Q24200518-FA68E6DE-8542-4317-A43A-7C67717BA88BQ24243664-95D9A242-9100-4FBB-A85A-4161E6F74BB1Q34247227-442239F5-5548-43F3-B2A3-59B3B60228A2Q35879879-9CCFED23-9182-4ADC-B713-B4A03B8491C2Q36817080-653AEB4E-3E71-4452-801F-1A058A690565Q37042501-A8E8EF6B-C9F0-4594-B480-13D37FED36E7Q37619114-4AC0BD21-37AF-4720-9F00-98F41801256DQ37645169-7F3CF2C6-0713-42C1-972D-39DB36103D65Q37709922-F23FAC92-4F63-408C-9A2B-50FE53D13741Q37986608-D7CECF3F-1858-4808-B69A-A41F9AE8FC83Q45820484-5E1CE263-26A1-4DFC-86EC-F89F27AE316E
P2860
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@ast
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@en
type
label
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@ast
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@en
prefLabel
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@ast
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@en
P2093
P356
P1476
Adding gemcitabine to paclitax ...... sults of a phase II-III study.
@en
P2093
Adriano Paccagnella
Alberto Riccardi
Antonio Chella
Fabrizio Veglia
Fausto Barbieri
Francesco Oniga
Giovanni Ceresoli
Maria Grazia Ghi
Maria Ornella Nicoletto
Maurizia Clerici
P304
P356
10.1200/JCO.2005.03.2722
P407
P577
2006-02-01T00:00:00Z